As of 2025-09-18, the Relative Valuation of Regenxbio Inc (RGNX) is (90.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.03 USD, the upside of Regenxbio Inc based on Relative Valuation is -1102.8%.
The range of the Relative Valuation is (81.34) - (88.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 25.5x | 22.3x |
| Forward P/E multiples | 23.4x - 31.4x | 29.8x |
| Fair Price | (81.34) - (88.78) | (90.55) |
| Upside | -1000.7% - -1083.1% | -1102.8% |
| Date | P/E |
| 2025-09-16 | -2.66 |
| 2025-09-15 | -2.62 |
| 2025-09-12 | -2.65 |
| 2025-09-11 | -2.73 |
| 2025-09-10 | -2.75 |
| 2025-09-09 | -2.85 |
| 2025-09-08 | -2.73 |
| 2025-09-05 | -2.79 |
| 2025-09-04 | -2.71 |
| 2025-09-03 | -2.84 |
| 2025-09-02 | -2.62 |
| 2025-08-29 | -2.57 |
| 2025-08-28 | -2.59 |
| 2025-08-27 | -2.54 |
| 2025-08-26 | -2.62 |
| 2025-08-25 | -2.58 |
| 2025-08-22 | -2.59 |
| 2025-08-21 | -2.33 |
| 2025-08-20 | -2.32 |
| 2025-08-19 | -2.31 |
| 2025-08-18 | -2.51 |
| 2025-08-15 | -2.54 |
| 2025-08-14 | -2.61 |
| 2025-08-13 | -2.57 |
| 2025-08-12 | -2.33 |
| 2025-08-11 | -2.15 |
| 2025-08-08 | -2.26 |
| 2025-08-07 | -2.27 |
| 2025-08-06 | -2.37 |
| 2025-08-05 | -2.38 |
| 2025-08-04 | -2.40 |
| 2025-08-01 | -2.36 |
| 2025-07-31 | -2.45 |
| 2025-07-30 | -2.52 |
| 2025-07-29 | -2.42 |
| 2025-07-28 | -2.53 |
| 2025-07-25 | -2.58 |
| 2025-07-24 | -2.63 |
| 2025-07-23 | -2.62 |
| 2025-07-22 | -2.47 |
| 2025-07-21 | -2.44 |
| 2025-07-18 | -2.35 |
| 2025-07-17 | -2.50 |
| 2025-07-16 | -2.45 |
| 2025-07-15 | -2.37 |
| 2025-07-14 | -2.50 |
| 2025-07-11 | -2.50 |
| 2025-07-10 | -2.61 |
| 2025-07-09 | -2.64 |
| 2025-07-08 | -2.51 |